span class=”Apple-style-span” style=”font-weight: bold;”Authentidate Holding Corp (ncm: ADAT) $0.27/span- Authentidate is attractively positioned to benefit from the expected flood of spending aimed at modernizing healthcare IT. Remote patient monitoring, also known as telehealth, is one area where Authentidate stands to capitalize due to its unique and superior product solution. Patient home monitoring is expected to be a $12 billion industry by 2012. ADAT will earn $120M in revenue if it achieves just 1% penetration. This compares to $6M in revenue Authentidate earned last fiscal year. There are a decent number of patient monitoring devices deployed currently, yet very few have actual “telemedicine” functionality, whereby a patient’s vitals are electronically transmitted to the healthcare provider coupled with any patient instructions subsequently relayed back to the patient. According to an InMedica study, there were less than 1 million telehealth subscribers in 2008, yet that number is expected to climb to over 55 …

Even as the government hands bailout-money to a slew of American banks and insurance providers, it is now refusing to provide GM and Chrysler with funding for a proposed merger. Word came from Bernanke and the Bush administration early on Friday, and it appears that for now, the deal is on hold. Nissan has been flagged as another possibility for Chrysler, as both automakers continue to struggle in a harsh economic environment.

Let us hear your thoughts below:

At Peridot Capital, I tend to ignore insider selling completely. Sure, a lot of sales inside a company can indicate management feels their stock is overpriced, but there are dozens of other reasons top brass sell stock, and they are never required to give the reason for their actions. Investors should be able to tell if a stock is grossly expensive or not on their own, if they indeed manage their own money, so insider selling data really can’t be relied upon.

Insider buying, however, I believe is crucially important. While I can make a laundry list of reasons why someone chooses to sell a stock, the reasons to buy are much fewer in number. In fact, there’s only one (to make money). It’s not surprising that studies have shown much more meaningful correlation to stock performance